Achieve Life Sciences (ACHV) Enterprise Value (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Enterprise Value of -$30.5 million in Q1 2026, up 16.24% on a QoQ basis from -$36.4 million in Q4 2025, and up 8.79% year-over-year from -$28.0 million in Q1 2025.
Achieve Life Sciences (ACHV) Enterprise Value (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Enterprise Value across 17 years of filings, most recently posting -$30.5 million for Q1 2026.
- Quarterly Enterprise Value rose 8.79% year-over-year to -$30.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.5 million (up 8.79% YoY) and the FY2025 annual result came in at -$36.4 million, down 5.95% from the prior year.
- Enterprise Value improved to -$30.5 million in Q1 2026, from -$36.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$12.8 million in Q1 2023 and troughed at -$107.9 million in Q2 2024.
- A 5-year average of -$40.1 million and a median of -$33.4 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 64.85% — and 2024, when it sank 420.4%.
- Tracing ACHV's Enterprise Value over 5 years: stood at -$22.8 million in 2022, then soared by 37.37% to -$14.3 million in 2023, then slumped by 141.09% to -$34.4 million in 2024, then decreased by 5.95% to -$36.4 million in 2025, then advanced by 16.24% to -$30.5 million in 2026.
- Business Quant data shows ACHV's Enterprise Value at -$30.5 million in Q1 2026, -$36.4 million in Q4 2025, and -$64.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | -30.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.49 Mn |
| Dec 31, 2025 | -36.40 Mn |
| Sep 30, 2025 | -64.28 Mn |
| Jun 30, 2025 | -55.40 Mn |
| Mar 31, 2025 | -33.43 Mn |
| Dec 31, 2024 | -34.36 Mn |
| Sep 30, 2024 | -76.27 Mn |
| Jun 30, 2024 | -107.86 Mn |
| Mar 31, 2024 | -66.40 Mn |
| Dec 31, 2023 | -14.25 Mn |
| Sep 30, 2023 | -17.92 Mn |
| Jun 30, 2023 | -25.10 Mn |
| Mar 31, 2023 | -12.76 Mn |
| Dec 31, 2022 | -22.76 Mn |
| Sep 30, 2022 | -18.20 Mn |
| Jun 30, 2022 | -29.40 Mn |
| Mar 31, 2022 | -36.30 Mn |
| Dec 31, 2021 | -43.02 Mn |
| Sep 30, 2021 | -33.31 Mn |
| Jun 30, 2021 | -42.00 Mn |